| Health / Medical Topics |
PADRE-CMV Fusion Peptide Vaccine
A peptide-based vaccine containing a pan HLA DR-binding epitope (PADRE) fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, PADRE-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. The synthetic peptide PADRE is a universal helper T cell epitope. (NCI Thesaurus)
YOU MAY ALSO LIKE
Pan-DR epitope (PADRE) 965.10 is a helper peptide. PADRE peptides have been shown the capacity to deliver help for antibody responses…
Human PADI4 wild-type allele is located in the vicinity of 1p36.13 and is approximately 56 kb in length. This allele, which encodes…
This gene is involved in arginine modification.
A vascular-acting photosensitizer consisting of a water-soluble, palladium-substituted bacteriochlorophyll derivative with potential antineoplastic activity. Upon administration, paldeliporfin is activated locally when the…
An abbreviation for a chemotherapy combination used to treat multiple myeloma. It includes the drugs bortezomib, doxorubicin (Adriamycin), and dexamethasone. Also called…
A dosing unit equal to the amount of active ingredient(s) contained in a pad.
